01 8VERTEX PHARMS INC
01 811517564
01 8Blank
01 8Y
01 82037-12-08
Patent Expiration Date : 2037-12-08
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 11517564
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212273
Patent Use Code : U-3498
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-12-08
Patent Expiration Date : 2037-12-08
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 11517564
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212273
Patent Use Code : U-4069
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-12-08
Patent Expiration Date : 2037-12-08
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 11517564
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212273
Patent Use Code : U-3498
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-12-08
Patent Expiration Date : 2037-12-08
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 11517564
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212273
Patent Use Code : U-4067
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-12-08
Patent Expiration Date : 2037-12-08
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 11517564
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 217660
Patent Use Code : U-3586
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-12-08
Patent Expiration Date : 2037-12-08
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 11517564
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 217660
Patent Use Code : U-4057
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-12-08
Patent Expiration Date : 2037-12-08
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 11517564
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 217660
Patent Use Code : U-3586
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-12-08
Patent Expiration Date : 2037-12-08
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 11517564
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 217660
Patent Use Code : U-4057
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-12-08
